Acute coronary syndrome: Clinical sciences

12,951views

Acute coronary syndrome: Clinical sciences

Watch later

Watch later

Pediatric lower airway conditions: Clinical
Prostate disorders and cancer: Pathology review
Muscle weakness: Clinical
Lower back pain: Clinical
Back pain: Pathology review
Pediatric infectious rashes: Clinical
Pediatric allergies: Clinical
Pediatric constipation: Clinical
Bites and stings: Clinical
Pediatric upper airway conditions: Clinical
Blistering skin disorders: Clinical
Antihistamines for allergies
Varicella zoster virus
Urinary incontinence: Pathology review
Acute pyelonephritis
Lower urinary tract infection
Meningitis, encephalitis and brain abscesses: Clinical
Meningitis
Hair, skin and nails
Neurofibromatosis
Benign hyperpigmented skin lesions: Clinical
Pulmonary corticosteroids and mast cell inhibitors
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Inflammatory myopathies: Clinical
Pediatric vomiting: Clinical
Diabetes mellitus: Clinical
Diabetes mellitus: Pathology review
Inflammatory bowel disease: Clinical
Peptic ulcers and stomach cancer: Clinical
Burns
Kidney stones
Kidney stones: Pathology review
Pediatric ear, nose, and throat conditions: Clinical
Upper respiratory tract infection
Acute respiratory distress syndrome: Clinical
Pressures in the cardiovascular system
Viral hepatitis
Hepatitis A and Hepatitis E virus
Viral hepatitis: Clinical
Viral hepatitis: Pathology review
Miscellaneous lipid-lowering medications
Peptic ulcer
Asthma: Clinical
Migraine medications
Headaches: Clinical
Kidney stones: Clinical
Renin-angiotensin-aldosterone system
Gout
Hypertension: Clinical
Gallbladder disorders: Clinical
ACE inhibitors, ARBs and direct renin inhibitors
Antiplatelet medications
Thrombolytics
Antimalarials
Atherosclerosis and arteriosclerosis: Pathology review
Bleeding disorders: Clinical
Miscellaneous hypoglycemics
Hypoglycemics: Insulin secretagogues
Pulmonary embolism
Chronic kidney disease: Clinical
Aortic dissection
Hypertensive disorders of pregnancy: Clinical
Azoles
Heart blocks: Pathology review
Alcohol use disorder
Lymphoma: Clinical
Heart failure: Pathology review
Seizures: Clinical
Necrosis and apoptosis
Vesiculobullous and desquamating skin disorders: Pathology review
Pericarditis and pericardial effusion
Approach to bradycardia: Clinical sciences
Sinusitis
Endocarditis
Endocarditis: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Myasthenia gravis
Neuromuscular junction disorders: Pathology review
Headaches: Pathology review
Movement disorders: Pathology review
Osteoarthritis: Clinical sciences
Approach to knee pain: Clinical sciences
Essential hypertension: Clinical sciences
Tuberculosis: Pathology review
Spinal cord disorders: Pathology review
Rheumatoid arthritis: Clinical sciences
Jaundice: Pathology review
Pneumonia (pediatrics): Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Cell wall synthesis inhibitors: Cephalosporins
Influenza: Clinical sciences
Drug misuse, intoxication and withdrawal: Alcohol: Pathology review
Osteoporosis medications
Collagen disorders: Pathology review
Microcytic anemia: Pathology review
Metaplasia and dysplasia
Colonic volvulus: Clinical sciences
Large bowel obstruction: Clinical sciences
Anatomy clinical correlates: Viscera of the gastrointestinal tract
Bowel obstruction
Intussusception
Small bowel ischemia and infarction
Congenital gastrointestinal disorders: Pathology review
Anatomy clinical correlates: Peritoneum and diaphragm
Gastrointestinal bleeding: Pathology review
Sickle cell disease (NORD)
Renal and urinary tract masses: Pathology review
Approach to anemia in the newborn and infant (destruction and blood loss): Clinical sciences
Hemophilia
Cirrhosis: Pathology review
Gastric cancer
Premature ventricular contraction
Approach to tremor: Clinical sciences
Jaundice
Acute stroke (ischemic or hemorrhagic) or TIA: Clinical sciences
Obesity and metabolic syndrome: Clinical sciences
Blood groups and transfusions
Approach to complications of prematurity (early): Clinical sciences
Paroxysmal nocturnal hemoglobinuria
Multiple myeloma
Introduction to pharmacology
Cartilage structure and growth
Aortic dissections and aneurysms: Pathology review
Local anesthetics
Approach to encephalitis: Clinical sciences
Acute coronary syndrome: Clinical sciences
Approach to dyspnea: Clinical sciences
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Spinal fractures: Clinical sciences
Pharyngitis, peritonsillar abscess, and retropharyngeal abscess (pediatrics): Clinical sciences
Pleural effusion

Decision-Making Tree

Transcript

Watch video only

Acute coronary syndrome, or ACS, is one of the can’t-miss-diagnoses that must be ruled out when a patient presents with acute chest pain. ACS is caused by sudden decreased coronary blood flow, also known as cardiac ischemia. The three types are ST-elevation myocardial infarction or STEMI, non-ST-elevation myocardial infarction or NSTEMI, and unstable angina, where the latter two are collectively referred to as non-ST-elevation or NSTE-ACS. STEMI results from complete acute blockage of a coronary artery, leading to transmural infarct of the myocardial wall supplied by that artery. NSTEMI results from a supply and demand mismatch, leading to non-transmural subendocardial infarct. Lastly, unstable angina also results from a supply and demand mismatch, leading to myocardial ischemia, but hasn’t yet caused infarction.

The first step in approaching a patient with chest pain is to do an initial assessment with a focused history and physical examination, or H&P, along with a 12-lead ECG. Prompt ECG should be obtained within 10 minutes of hospital arrival and shouldn’t be delayed by H&P. When chest pain is due to cardiac ischemia, it usually worsens with exertion, is not relieved with rest, and doesn’t change with body positioning. Some patients may complain of chest discomfort, pressure, tightness, or burning-like sensation, as well as palpitationsdyspneadiaphoresis, nausea and vomiting, dizziness, and syncopeIschemic chest pain often radiates to other parts of the body, including the epigastrium, left shoulder and arm, neck, and lower jaw. Relevant medical history in patients with chest pain includes hypertension, dyslipidemiadiabetestobacco use, and a family history of myocardial infarctions.

Physical examination findings in patients with ACS can be variable, since proximal blockages in large vessels result in more myocardial damage than distal blockages in smaller branches. If a large myocardial area is affected, it can lead to decreased cardiac output. As a result, physical examination may show signs of cardiogenic shock, such as hypotension, tachycardia, diaphoresis, cool extremities, and pale skin. In addition, some patients may have evidence of acute heart failure, which is characterized by jugular venous distension, crackles on lung auscultation, new S3 gallop, new or worsening murmurorthopnea and edema.

If there’s suspicion of ACS based on H&P, markers of myocardial injury like troponin should be obtained.

Some high yield facts to keep in mind! If a patient has a history of stable angina, changes in their presentation that may suggest ACS include chest pain at rest for more than 20 minutes at a time, new onset chest pain that greatly limits their physical activity, or a change from their baseline angina in terms of frequency, duration, or onset of chest pain with less exertion. Also, some patients, particularly both cis and trans females, older patients, and those with diabetes may present with dyspnea rather than chest pain.

While performing the initial assessment, establish IV access and attach cardiac and oxygen saturation monitors. Then, start MONA. M is for morphine, which is administered IV to manage pain. O stands for oxygen supplementation, which might be needed to maintain the patient’s O2 saturation above 90%. N is for nitrates, which can be administered sublingually or less commonly IV for vasodilation to improve blood flow to the myocardium. Lastly, A is for high-dose aspirin, which is 325 mg, and it’s given for its antiplatelet properties to prevent complete thrombosis. In addition to MONA, also give a high-intensity statin like high-dose atorvastatin to stabilize the plaque. Finally, give a beta blocker like metoprolol to decrease myocardial oxygen demand and decrease mortality.

Okay, now that you’ve done the initial assessments and acute management, it’s time to check the ECG results for STEMI. If ST segment elevation is seen in two contiguous leads, it confirms the diagnosis of STEMI. However, a left bundle branch block or LBBB can mask ST elevation, so the diagnosis can also be made if there’s a new LBBB with a presentation consistent with ACS. LBBB typically present as QRS longer than 120 ms, a dominant S wave in V1, broad notched R waves, and absent Q waves in the lateral leads like V6.

Once a STEMI diagnosis is made, get a cardiology consultation to help guide management steps. The primary goal of treatment should be to quickly reperfuse the ischemic tissue to limit myocardial necrosis. But first, additional medical therapy needs to be given as long as it does not delay starting reperfusion therapy. All patients should receive dual antiplatelet therapy or DAPT, which includes adding an oral antiplatelet medication on top of the aspirin they have already received. Similarly, they should also receive an anticoagulant to reduce the risk of thrombosis-related ischemic events.

Now, let’s look at the options for reperfusion therapy.

Sources

  1. "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [published correction appears in J Am Coll Cardiol. 2025 May 13;85(18):1800. doi: 10.1016/j.jacc.2025.03.500.]. ;85(22):2135-2237." J Am Coll Cardiol (2025)
  2. "2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [published correction appears in J Am Coll Cardiol. 2024 Oct 29;84(18):1771. doi: 10.1016/j.jacc.2024.09.024.]. 78(22):e187-e285." J Am Coll Cardiol (2021)
  3. "Fourth Universal Definition of Myocardial Infarction (2018). 72(18):2231-2264." J Am Coll Cardiol. (2018)
  4. "ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines" Journal of the American College of Cardiology (2013 )
  5. "The heart. In: Aster, JC, Abbas AK, Kumar V, Debnath J, Das A, eds. Robbins, Cotran & Kumar Pathologic Basis of Disease. 11th ed. 479-529. " Philadelphia, PA: Elsevier (2026)